Elmiron Eye Lawsuit News

Attorney Danielle Gold Appointed To Lead Elmiron Lawsuit MDL

Attorneys reflect the predominance of womenthat have been injured by allegedly taking Elmiron

Monday, February 8, 2021 - Plaintiffs that have filed suit against Janssen and Johnson & Johnson after using Elmiron have been organized into multidistrict litigation that will be spearheaded by Attorney Danielle Gold. PRNewswire writes, "attorney Danielle Gold - of the prominent "mass torts litigation" law firm Weitz & Luxenberg P.C. (New York) has been appointed to serve on the Plaintiffs' Executive Committee in the Elmiron multidistrict litigation (MDL). The litigation alleges that taking pentosan polysulfate sodium (PPS) to reduce bladder pain and discomfort of interstitial cystitis has resulted in serious eye damage." Ms. Gold's appointment reflects that most of the plaintiffs claiming that Elmiron caused their eyesight damage are women themselves. If you have taken Elmiron regularly for more than five years and are experiencing trouble seeing at night or reading in sub-optimal lighting conditions, you may have developed maculopathy.

FDA-approved Elmiron is prescribed primarily for women with painful bladder syndrome called interstitial cystitis (IC). There is no known cure for IC and taking Elmiron is accepted as the only treatment. Harvard Health explains, "Elmiron is the only oral drug approved by the FDA specifically for interstitial cystitis. It improves the bladder lining, making it less leaky and therefore less inflamed and painful. Women with IC take Elmiron for up to three months before the drug accumulates enough in the blood to begin pain relief.

Thousands of women are expected to come forward in the months to come in 2021 and beyond to file a legal claim against Janssen Pharmaceuticals and their parent company Johnson & Johnson, for failing to warn patients and physicians about Elmiron's propensity to cause night blindness called maculopathy. A patient with maculopathy experiences damage to the light-sensing tissue at the back of the eye that allows us to see called the retina. Macular degeneration, once thought to be a normal part of the aging process, is now being linked to people that have taken Elmiron. Ophthalmologists studying women that have been prescribed Elmiron have concluded that about one in four have experienced significant eyesight damage and the longer one had taken Elmiron, the greater the damage. The recent study analyzed about 100 women that had taken about 5000 Elmiron tables each over 15 years. Science Daily reports that one of the study's authors, Dr. Robin Vora concluded, "Twenty-two of the 91 patients showed clear signs of drug toxicity. The rate of toxicity rose with the amount of drug consumed, from 11 percent of those taking 500 to 1,000 grams to 42 percent of those taking 1,500 grams or more. It's unfortunate. You have a patient with a chronic condition like interstitial cystitis, for which there is no cure and no effective treatment. They get put on these medications because it's thought to have few side effects and few risks, and no one thinks about it again. And year after year, the number of pills they're taking goes up and up."

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.